CEL-SCI Corp 2026年季度报告

CEL-SCI CORPORATION Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the SecuritiesExchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports) Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted andposted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smallerreporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smallerreporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act: Indicate by check mark whether the Registrant is a shell company (as defined in Exchange Act Rule 12b-2 of the Exchange Act). Yes☐No☒ TABLE OF CONTENTS PART I FINANCIAL INFORMATION Item 1. CEL-SCI CORPORATIONCONDENSED STATEMENTS OF OPERATIONS CEL-SCI CORPORATIONSTATEMENTS OF CASH FLOWS CEL-SCI CORPORATIONNOTES TO CONDENSED FINANCIAL STATEMENTS A. BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying condensed financial statements of CEL-SCI Corporation (the “Company”) are unaudited and certaininformation and footnote disclosures normally included in the annual financial statements prepared in accordance withaccounting principles generally accepted in the United States of America have been omitted pursuant to the rules and In the opinion of management, the accompanying unaudited condensed financial statements contain all adjustments (all ofwhich are of a normal recurring nature) and disclosures necessary for a fair presentation of the Company’s financial positionas of December 31, 2025 and the results of its operations for the three months then ended. The condensed balance sheet as of Due to recurring losses from operations and future liquidity needs, there is substantial doubt about the Company’s ability tocontinue as a going concern. The financial statements do not include any adjustments that might result from the outcome of On May 19, 2025, the Company’s shareholders approved a reverse split of the Company’s common stock which becameeffective on the NYSE American on May 20, 2025. On that date, every thirty issued and outstanding shares of the Company’scommon stock automatically converted into one outstanding share. As a result of the reverse stock split, the number of theCompany’s outstanding shares of common stock decreased from 94,037,256 (pre-split) shares to 3,135,021 (post-split) shares.In addition, by reducing the number of the Company’s outstanding shares, the Company’s loss per share in all prior periods As the par value per share of the Company’s common stock remained unchanged at $0.01 per share, a total of $909,021 wasreclassified from common stock to additional paid-in capital. In connection with this reverse stock split, the number of sharesof common stock reserved for issuance under the Company’s incentive and non-qualified stock option plans, as well as theshares of common stock underlying outstanding stock options and warrants, were also proportionately reduced while the Summary of Significant Accounting Policies: Cash and Cash Equivalents– Cash and cash equivalents consist principally of unrestricted cash on deposit and short-termmoney market funds. The Company considers all highly liquid investments with a maturity when purchased of less than three Property and Equipment– Property and equipment is recorded at cost and depreciated using the straight-line method overestimated useful lives of five to seven years. Leasehold improvements are depreciated over the shorter of the estimated usefullife of the asset or the term of the lease. Repairs and maintenance which do not extend the life of the asset are expensed when Supplies used for R&D and manufacturing –Supplies are consumable items kept on hand to support the Company’s R&D andmanufacturing operations. Supplies are recorded at the lower of cost or net realizable value and are charged to expense as theyare used in operations. The Company regularly reviews the quality and utilization of supplies to determine if future use ofthese supplies is probable. Due to the generic use of these supplies, they can be used in multiple projects other than those Patents costs, net– Patent expenditures are capitalized and amortized using the straight-line method over the shorter of theexpected useful life or the legal life of the patent (17 years). In the event changes in technology or other circumstances impairthe value or life of the patent, appropriate adjustments to the asset value and period of amortization are made. An impairment Leases –The Company accounts for contracts that convey the right to